Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Directional preference for glioblastoma cancer cell membrane encapsulated nanoparticle population: A probabilistic approach for cancer therapeutics. | Front Immunol | 2023 | 37063901 | PubTator, text mining | PubMed |
| Role of T-box transcription factor 3 in gastric cancers. | World J Gastrointest Pathophysiol | 2023 | 37035275 | PubTator, text mining | PubMed |
| An in-silico approach leads to explore six genes as a molecular signatures of lung adenocarcinoma. | Am J Cancer Res | 2023 | 37034228 | PubTator, text mining | PubMed |
| Network and functional analyses of differentially expressed genes in gastric cancer provide new biomarkers associated with disease pathogenesis. | J Egypt Natl Canc Inst | 2023 | 37032412 | PubTator, text mining | PubMed |
| Identification immune response genes in psoriasis after treatment with secukinumab. | BMC Med Genomics | 2023 | 37029373 | PubTator, text mining | PubMed |
| Discriminative pattern discovery for the characterization of different network populations. | Bioinformatics | 2023 | 37021928 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| FYN/TOPK/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer. | J Exp Clin Cancer Res | 2023 | 37016377 | PubTator, text mining | PubMed |
| Correction to "T-LAK cell-originated protein kinase (TOPK) is a novelprognostic and therapeutic target in chordoma". | Cell Prolif | 2023 | 37010055 | PubTator, text mining | PubMed |
| Predictive Value of Gene Databases in Discovering New Biomarkers and New Therapeutic Targets in Lung Cancer. | Medicina (Kaunas) | 2023 | 36984548 | PubTator, text mining | PubMed |
| Demystifying the Role of Prognostic Biomarkers in Breast Cancer through Integrated Transcriptome and Pathway Enrichment Analyses. | Diagnostics (Basel) | 2023 | 36980449 | PubTator, text mining | PubMed |
| The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma. | Heliyon | 2023 | 36967927 | PubTator, text mining | PubMed |
| ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation. | Cell Death Dis | 2023 | 36966163 | PubTator, text mining | PubMed |
| Targeted therapies in advanced biliary tract cancers-a narrative review. | Chin Clin Oncol | 2023 | 36946186 | PubTator, text mining | PubMed |
| Relationship between the deep features of the full-scan pathological map of mucinous gastric carcinoma and related genes based on deep learning. | Heliyon | 2023 | 36942252 | PubTator, text mining | PubMed |
| Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients. | BMC Bioinformatics | 2023 | 36941564 | PubTator, text mining | PubMed |
| Specific gene expression signatures of low grade meningiomas. | Front Oncol | 2023 | 36937440 | PubTator, text mining | PubMed |
| Prognosis and Characterization of Microenvironment in Cervical Cancer Influenced by Fatty Acid Metabolism-Related Genes. | J Oncol | 2023 | 36936374 | PubTator, text mining | PubMed |
| The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo. | J Ginseng Res | 2023 | 36926617 | PubTator, text mining | PubMed |
| Ginsenoside Rh2 suppresses colon cancer growth by targeting the miR-150-3p/SRCIN1/Wnt axis. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 36916297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=14